Abstract
Acute myocardial infarction is the consequence of sudden, complete obstruction of a major coronary artery [1]. It carries a mortality of about 10% with a significant morbidity [2]. Five distinct pathological processes take place in the infarct-related coronary artery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
DeWood MA, Spores J, Notske R, Mouser LT, Borroughs R, Golden MS, Lang HT (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303: 897–902
Corday E, Corday SR (1983) Advances in clinical management of acute myocardial infarction in the past 25 years. J Am Coll Cardiol 1: 126–132
Woolf N (1982) Pathology of atherosclerosis. Butterworth, London
Falk E (1983) Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Br Heart J 50: 127–134
Maseri A, L’Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, Severi S, Parodi O, Biagini A, Distante A, Pesola A (1978) Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of “preinfarction” angina. N Engl J Med 299: 1271–1277
Horie T, Seckiguchi M, Hirosawa K (1978) Coronary thrombosis in the pathogenesis of acute myocardial infarction. Br Heart J 40: 153–161
Muller JE (1983) Coronary artery thrombosis: historical aspects. J Am Coll Cardiol 1: 893–896
Rentrop KP, Feit F, Blanke H, Stecy P, Schneider R, Rey M, Horowitz S, Goldman M, Karsch K, Meilman H, Cohen M, Siegel S, Sanger J, Slater J, Gorlin R, Fox A, Fagerstrom R, Calhoun WF (1984) Effects of intracoronary streptokinase and intracoronary nitroglycerine infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. N Engl J Med 311: 1457–1463
Jennings RB, Reimer KA (1981) Lethal myocardial ischemic injury. Am J Pathol 102: 241–255
Reimer KA, Jennings RB (1979) The “wave front phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the frame work of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40: 633–644
Mathey DG, Sheehan FH, Schofer J, Dodge HT (1985) Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction. J Am Coll Cardiol 6: 518–525
Koren G, Weiss AT, Hasin Y, Applebaum D, Weiber S, Rozenman Y, Lotan C, Mosseri M, Sapoznikov D, Luria MH, Gotsman MS (1985) Prevention of myocardial damage by very early treatment with intravenous streptokinase. N Engl J Med 313: 1384–1389
Fine DG, Weiss AT, Sapoznikov D, Weiber S, Applebaum D, Lotan C, Hasin Y, Ben-David Y, Koren G, Gotsman MS (1986) Importance of early initiation of intravenous streptokinase therapy for acute myocardial infarction. Am J Cardiol 58: 411–417
Simoons ML, Serruys PW, Van den Braud M, Res J, Yerheugt FWA, Hanno Krauss X, Remme WJ, Bar F, DeZwaan C, van den Larse A, Vermeer F, Lubsen J (1986) Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol 7: 717–728
Kennedy JW, Ritchie JL, Davis KB, Fritz JK (1983) Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 308: 1477–1482
ISAM Study Group (1986) A prospective trial of intravenous streptokinase in acute myocardial infarction. N Engl J Med 314: 1465–1471
The GISSI Study Group (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1: 397–401
Yusuf S, Collins R, Peto R, Furberg C, Stamper MJ, Gaddhaber ST, Henmekens CH (1985) Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, re-infarction and side-effects from 33 randomized controlled trials. Eur Heart J 6: 556–585
Sheehan FH, Mathey DG, Schofer J, Krebber HJ, Dodge HT (1983) Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase. Am J Cardiol 52: 431–438
Applebaum D, Weiss AT, Koren G, Hasin Y, Gotsman MS (1986) Feasibility of pre-hos- pital fibrinolytic therapy of acute myocardial infarction by emergency medical services. J Emerg Med 4: 207–210
Weiss AT, Fine DG, Applebaum D, Weiber S, Lotan C, Sapoznikov D, Mosseri M, Ben- David Y, Hasin Y, Gotsman MS (1987) Prehospital coronary thrombolysis: a new strategy in acute myocardial infarction. Chest 92: 124–128
Norris RN, Whitlock RML, Barratt-Boyes C, Small CW (1975) Clinical measurement of myocardial infarct size: modification of a method for the estimation of total creatine phos- pho-kinase release after myocardial infarction. Circulation 51: 614–620
Selvester RH, Wagner JO, Rubin HB (1972) Quantitation of myocardial infarct size and location by electrocardiogram and vectorcardiogram. In: Snellin HA (ed) Boerhave course on quantitation in cardiology. Leiden, University Press 2: 31–34
Hindman NB, Schocken DD, Windman M, Anderson WD, White RD, Leggett S, Ideker RE, Hinchara T, Selvester RH, Wagner GS (1985) Evaluation of a QRS scoring system for estimating myocardial infarct size. V: Specificity and method of application of the complete system. Am J Cardiol 55: 1485–1490
Sapoznikov D, Halon DA, Lewis BA, Gotsman MS (1981) Regional ejection fraction of the normal left ventricle. Isr J Med Sei 17: 1027–1034
Sapoznikov D, Halon DA, Lewis BS, Weiss AT, Gotsman MS (1983) Frame by frame analysis of the left ventricular function: quantitative assessment of regional and temporal function. Cardiology 70: 61–72
Sapoznikov D, Weiber S, Lotan C, Mosseri M, Shimoni Y, Gotsman MS. Quantitation of variations in regional left ventricular function in isolated disease of the left anterior descending coronary artery. Cardiology (In press)
Sherman CT, Litvak F, Grundfest W, Lee M, Hickey A, Chaux A, Kass R, Blanche C, Mat- loff J, Morgenstern L, Ganz W, Swan HJC, Forrester J (1986) Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med 315: 913–919
Essen R, Schmidt W, Uebis R, Edelman B, Effert S, Silny J, Rav G (1985) Myocardial infarction and thrombolysis: electrocardiographic short term and long term results using precordial mapping. Br Heart J 54: 6–10
Fletcher AP, Alkjaersig J, Sherry S (1959) The maintenance of a sustained thrombolytic state in man: induction and effects. J Clin Invest 38: 1096
Smith RAG, Dupe RJ, English PD, Green J (1981) Fibrinolysis with acyl enzymes. A new approach to thrombolytic therapy. Nature 290: 505–508
Van de Werf F, Bergmann SR, Fox KA, Geest H, de Hoying CF, Sobel BE, Collen D (1984) Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. Circulation 69: 605–610
Verstraete M, Bory M, Collen D, Erbel R, Lennane RJ, Mathey D, Michels HR, Schartl M, Uebis R, Bernard R, Browler RW, DeBono DP, Huhmann W, Lubsen J, Meyer J, Rutsch W, Schmidt W, Essen R (1985) Randomized trial of intravenous recombinant tissue- type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1: 842–847
The TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial - phase I findings. N Engl J Med 312: 932–936
Harrison DG, Ferguson DW, Collins SM, Skorton DJ, Eriksen EE, Kioschos JM, Marcus ML, White CW (1984) Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. Circulation 69: 991–999
Gangadharan V, Ramos RG, Hauser AM, Westveer DC, Timmis GG, Gordon S (1982) In- tra-coronary streptokinase: evidence for continued iatrogenic or spontaneous thrombolysis after termination of infusion. Am J Cardiol 49: 973
Karsch K, Blanke H, Pichard A, Driesman M, Gorlin R, Teicholz LE, Rentrop KP (1981) Changes in the degree of stenosis of the infarct vessel following intracoronary streptokinase. Circulation 64: 105–107
Schroder R, Voringer M, Linderer T, Blamino G, Bruggermann T, Leitner ER (1985) Follow up after coronary arterial reperfusion with intravenous streptokinase in relation to residual myocardial infarct artery narrowing. Am J Cardiol 55: 313–317
Sheehan FH, Mathey DG, Schofer J, Dodge HT, Bolson EL (1985) Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarction. Circulation 71: 1121–1128
Gold AK, Leinbach RC, Palacios IF, Yasuda T, Block PC, Buckley MJ, Akins CW, Daggett WM, Austen WG (1983) Coronary re-occlusion after selective administration of streptokinase. Circulation 68: 150–154
Gash AK, Spann JF, Sherry S, Belber AD, Carabello BA, McDonough MT, Mann RH, McCann WD, Gault JH, Gantzler RD, Kent RL (1986) Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction. Am J Cardiol 57: 175–177
Gold HK, Leinbach RC, Garabedian HD, Tsunheiro-Yasuda Sin, Johns JA, Grossbard EB, Palacios I, Collen D (1986) Acute coronary re-occlusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation 23: 347–352
Chesebro JH, Fuster V (1986) Anti-thrombotic therapy for acute myocardial infarction: mechanism and prevention of deep venous, left ventricular and coronary artery thromboembolism. Circulation 74 (Suppl 3): 1–10
Serruys PW, Wign SW, Van der Brand M (1983) Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study. Br Heart J 50: 257
Hammerman H, Kloner RA, Briggs LL, Braunwald E (1984) Enhancement of salvage of re- perfused myocardium by early beta-adrenergic blockade (timolol). J Am Coll Cardiol 3: 1438–1443
Nayler WG (1980) Cardioprotective effects of calcium ion antagonists in myocardial ischemia. Clin Invest Med 3: 91
Shlafer M, Kane PF, Kirsh MM (1982) Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic reperfused heart. J Thorac Cardiovasc Surg 83: 830–839
Kitazume H, Iwama T, Suzuki A (1986) Combined thrombolytic therapy and coronary angioplasty for acute myocardial infarction. Am Heart Jill: 826–832
Hartzler GO, Rutherford BD, McConahay DR, Johnson WL, McCallister BD, Gura GM, Conn RC, Crockett JE (1983) Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 106: 965–973
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gotsman, M.S. et al. (1989). Early and Prehospital Thrombolytic Therapy in Acute Myocardial Infarction. In: Schmutzler, H., Rutsch, W., Dougherty, F.C. (eds) Limitation of Infarct Size. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73585-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-73585-1_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19148-3
Online ISBN: 978-3-642-73585-1
eBook Packages: Springer Book Archive